There are many treatment options for multiple sclerosis (MS ... Medication DMTs for MS include oral medications — medications you swallow — and non-oral medications, which are injected ...
High-dose vitamin D supplementation reduces disease activity in clinically isolated syndrome typical of MS, results of a ...
About Vidofludimus Calcium (IMU-838) Vidofludimus calcium is a small molecule investigational drug in development as an oral next-generation treatment option for patients with multiple sclerosis ...
and in early relapsing-remitting multiple sclerosis (MS), the D-Lay MS clinical trial showed. Over 24 months of follow-up, disease activity occurred in 60.3% of the group taking 100,000 IU oral ...
Top-Line Data from Phase 2 CALLIPER Trial of Vidofludimus Calcium in Progressive Multiple Sclerosis Expected in April – NEW YORK, Feb. /PRNewswire/ -- Immunic, Inc.